DNA methylation marker identification and poly-methylation risk score in prediction of healthspan termination.

IF 3 4区 医学 Q2 GENETICS & HEREDITY Epigenomics Pub Date : 2024-04-01 Epub Date: 2024-03-14 DOI:10.2217/epi-2023-0343
Meiqi Yang, Mei Wang, Xiaoyu Zhao, Feifei Xu, Shuang Liang, Yifan Wang, Nanxi Wang, Muhammed Lamin Sambou, Yue Jiang, Juncheng Dai
{"title":"DNA methylation marker identification and poly-methylation risk score in prediction of healthspan termination.","authors":"Meiqi Yang, Mei Wang, Xiaoyu Zhao, Feifei Xu, Shuang Liang, Yifan Wang, Nanxi Wang, Muhammed Lamin Sambou, Yue Jiang, Juncheng Dai","doi":"10.2217/epi-2023-0343","DOIUrl":null,"url":null,"abstract":"<p><p><b>Aim:</b> To elucidate the epigenetic consequences of DNA methylation in healthspan termination (HST), considering the current limited understanding. <b>Materials & methods:</b> Genetically predicted DNA methylation models were established (n = 2478). These models were applied to genome-wide association study data on HST. Then, a poly-methylation risk score (PMRS) was established in 241,008 individuals from the UK Biobank. <b>Results:</b> Of the 63,046 CpGs from the prediction models, 13 novel CpGs were associated with HST. Furthermore, people with high PMRSs showed higher HST risk (hazard ratio: 1.18; 95% CI: 1.13-1.25). <b>Conclusion:</b> The study indicates that DNA methylation may influence HST by regulating the expression of genes (e.g., <i>PRMT6</i>, <i>CTSK</i>). PMRSs have a promising application in discriminating subpopulations to facilitate early prevention.</p>","PeriodicalId":11959,"journal":{"name":"Epigenomics","volume":" ","pages":"461-472"},"PeriodicalIF":3.0000,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Epigenomics","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2217/epi-2023-0343","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/3/14 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"GENETICS & HEREDITY","Score":null,"Total":0}
引用次数: 0

Abstract

Aim: To elucidate the epigenetic consequences of DNA methylation in healthspan termination (HST), considering the current limited understanding. Materials & methods: Genetically predicted DNA methylation models were established (n = 2478). These models were applied to genome-wide association study data on HST. Then, a poly-methylation risk score (PMRS) was established in 241,008 individuals from the UK Biobank. Results: Of the 63,046 CpGs from the prediction models, 13 novel CpGs were associated with HST. Furthermore, people with high PMRSs showed higher HST risk (hazard ratio: 1.18; 95% CI: 1.13-1.25). Conclusion: The study indicates that DNA methylation may influence HST by regulating the expression of genes (e.g., PRMT6, CTSK). PMRSs have a promising application in discriminating subpopulations to facilitate early prevention.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
DNA 甲基化标记鉴定和多甲基化风险评分在预测健康寿命终止中的作用。
目的:考虑到目前对 DNA 甲基化在健康终结(HST)中的表观遗传学影响的了解有限,旨在阐明其在健康终结中的影响。材料与方法建立遗传预测 DNA 甲基化模型(n = 2478)。这些模型被应用于有关 HST 的全基因组关联研究数据。然后,在英国生物库的 241 008 个个体中建立了多甲基化风险评分(PMRS)。结果显示在预测模型得出的 63046 个 CpGs 中,有 13 个新的 CpGs 与 HST 相关。此外,PMRS 较高的人显示出更高的 HST 风险(危险比:1.18;95% CI:1.13-1.25)。结论研究表明,DNA甲基化可能会通过调节基因(如 PRMT6、CTSK)的表达来影响 HST。PMRS 在区分亚群以促进早期预防方面具有广阔的应用前景。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Epigenomics
Epigenomics GENETICS & HEREDITY-
CiteScore
5.80
自引率
2.60%
发文量
95
审稿时长
>12 weeks
期刊介绍: Epigenomics provides the forum to address the rapidly progressing research developments in this ever-expanding field; to report on the major challenges ahead and critical advances that are propelling the science forward. The journal delivers this information in concise, at-a-glance article formats – invaluable to a time constrained community. Substantial developments in our current knowledge and understanding of genomics and epigenetics are constantly being made, yet this field is still in its infancy. Epigenomics provides a critical overview of the latest and most significant advances as they unfold and explores their potential application in the clinical setting.
期刊最新文献
SNHG12 in cancer-associated fibroblast-derived extracellular vesicle induces macrophage-myofibroblast transition. Prenatal chemical exposures and the methylome: current evidence and opportunities for environmental epigenetics. The potential utility of cord blood DNA methylation in pediatric clinical practice. DNA methylation analysis of multiple genes in thymic epithelial tumors. The Two Faces of HDAC3: Neuroinflammation in Disease and Neuroprotection in Recovery.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1